Peter Blume-Jensen - Insider Trading & Ownership

Location
C/O Acrivon Therapeutics, Inc., 480 Arsenal Way, Suite 100, Watertown, MA
Summary
The estimated net worth of Peter Blume-Jensen is at least $3.23M dollars as of August 25, 2025. Peter Blume-Jensen is the President and CEO, Director of Acrivon Therapeutics, Inc. and owns shares of Acrivon Therapeutics, Inc. (ACRV) stock worth about $3.23M.
Signature
/s/ Mary-Alice Miller, Attorney-in-Fact for Peter Blume-Jensen
All Insider Reports
All Insider Reports

Ownership of Peter Blume-Jensen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACRV Acrivon Therapeutics, Inc. President and CEO, Director $3.23M Aug 21, 2025

Insider Transactions Reported by Peter Blume-Jensen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.